Colo et al (12) reported that SRC-3 was over-expressed in human chronic myeloid leukemia K562 cells and resisted tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. The gene discussed is NCOA3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.